Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,024.09 20.57 (1.97%) as of 4:30 Wed 7/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 107.21(B)
Last Volume: 378,341 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 191,758 236,826 311,409 468,643
Total Sell Value $188,359,854 $231,314,072 $294,701,490 $404,818,815
Total People Sold 7 13 16 18
Total Sell Transactions 16 39 65 127
End Date 2024-04-04 2024-01-02 2023-07-04 2022-07-04

   
Records found: 2433
  Page 65 of 98  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Schleifer Leonard S President & CEO   •       •      –    2013-03-05 4 AS $175.21 $3,354,571 D/D (19,146) 222,941     -
   Shooter Eric M Director   –       •      –    2013-02-26 4 S $160.00 $1,600,000 I/I (10,000) 2,500     -
   Shooter Eric M Director   –       •      –    2013-02-26 4 A $0.00 $0 I/I 10,000 7,500     -
   Goldberg Murray A SVP Finance and Admin CFO Trea   •       –      –    2013-01-16 4 AS $170.57 $1,356,272 D/D (7,878) 58,592     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2013-01-09 4 OE $16.80 $99,980 D/D 5,752 20,742     -
   Goldstein Joseph L Director   –       •      –    2013-01-09 4 AS $185.00 $925,000 D/D (5,000) 0     -
   Goldstein Joseph L Director   –       •      –    2013-01-09 4 OE $57.11 $285,550 D/D 5,000 5,000     -
   Vagelos P Roy Chairman of the Board   •       •      –    2013-01-08 4 GD $0.00 $0 I/I 1,254 161,403     -
   Goldstein Joseph L Director   –       •      –    2013-01-04 4 AS $180.50 $904,127 D/D (5,000) 0     -
   Goldstein Joseph L Director   –       •      –    2013-01-04 4 OE $33.42 $167,100 D/D 5,000 2,740     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2013-01-03 4 AS $180.83 $2,474,091 D/D (13,586) 14,990     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2013-01-02 4 D $177.82 $2,918,737 D/D (16,414) 28,576     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2013-01-02 4 OE $21.25 $637,500 D/D 30,000 44,990     -
   Schleifer Leonard S President & CEO   •       •      –    2012-12-24 4 GD $0.00 $0 D/D 59,271 242,087     -
   Van Plew Daniel P SVP & Gen Mgr IOPS   •       –      –    2012-12-20 4 OE $16.80 $34,440 D/D 2,050 6,834     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2012-12-20 4 AS $170.44 $1,130,164 D/D (6,623) 14,990     -
   Yancopoulos George EVP CSO Pres Regen Res Labs   •       •      –    2012-12-19 4 OE $9.49 $699,978 D/D 50,846 1,117,330     -
   Mccorkle Douglas S VP Controller & Asst Treasurer   •       –      –    2012-12-19 4 AS $174.52 $322,986 D/D (1,841) 4,000     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2012-12-19 4 AS $176.79 $1,848,536 D/D (10,356) 21,613     -
   Mccorkle Douglas S VP Controller & Asst Treasurer   •       –      –    2012-12-18 4 AS $177.46 $134,606 D/D (752) 5,841     -
   Mccorkle Douglas S VP Controller & Asst Treasurer   •       –      –    2012-12-18 4 OE $21.25 $98,281 D/D 4,625 6,041     -
   Mccorkle Douglas S VP Controller & Asst Treasurer   •       –      –    2012-12-18 4 D $178.62 $362,956 D/D (2,032) 5,841     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2012-12-18 4 D $178.62 $3,799,069 D/D (21,269) 31,969     -
   Powchik Peter SVP Clin Devel & Reg Affairs   •       –      –    2012-12-18 4 OE $21.25 $1,209,090 D/D 38,248 39,446     -
   Aberman Michael S VP Strategy and Investor Relat   •       –      –    2012-12-18 4 OE $24.00 $28,800 D/D 1,200 11,700     -
  2433 Records found
  Previous  60  61  62  63  64  65  66  67  68  69  Next   
  Page 65 of 98
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us